Skip to main content
. 2019 Sep 13;11:855–871. doi: 10.2147/CLEP.S213136

Table S4.

Distribution of comorbidities in patients with tinnitus and their matched controls, stratified by sex: head and neck disorders

Men (n=53,874) Women (n=55,909)
Tinnitus cases (%) Tinnitus-free controls (%) OR crude (95% CI) OR adjusteda (95% CI) Tinnitus cases (%) Tinnitus-free controls (%) OR crude (95% CI) OR adjusteda (95% CI)
Tension-type headache
 ≤30 days prior to (includigng) the ID 38 (0.1) 0 (0.0) NA NA 66 (0.1) 9 (0.0) 7.47 (3.72–14.99) 7.55 (3.76–15.18)
 31 to 360 days prior to the ID 117 (0.2) 48 (0.1) 2.47 (1.77–3.46) 2.38 (1.70–3.35) 242 (0.4) 97 (0.2) 2.56 (2.02–3.24) 2.57 (2.03–3.26)
 >360 days prior to the ID 1143 (2.1) 708 (1.3) 1.64 (1.49–1.81) 1.57 (1.43–1.73) 2188 (3.9) 1468 (2.6) 1.54 (1.44–1.65) 1.52 (1.42–1.63)
Concussion
 ≤30 days prior to (includigng) the ID 14 (0.0) <5b (0.0) 14.00 (1.84–106.41) 13.36 (1.74–102.45) 11 (0.0) <5b (0.0) 5.50 (1.22–24.80) 5.98 (1.32–27.08)
 31 to 360 days prior to the ID 15 (0.0) 7 (0.0) 2.14 (0.87–5.26) 2.31 (0.93–5.75) 24 (0.0) 12 (0.0) 2.00 (1.00–4.00) 2.00 (1.00–4.01)
 >360 days prior to the ID 332 (0.6) 324 (0.6) 1.03 (0.88–1.20) 1.02 (0.88–1.20) 207 (0.4) 173 (0.3) 1.20 (0.98–1.47) 1.21 (0.99–1.49)
Temporomandibular joint disorders
 ≤30 days prior to (includigng) the ID 38 (0.1) 7 (0.0) 5.43 (2.42–12.15) 5.27 (2.34–11.85) 77 (0.1) 10 (0.0) 7.81 (4.05–15.10) 7.59 (3.92–14.70)
 31 to 360 days prior to the ID 106 (0.2) 38 (0.1) 2.80 (1.93–4.06) 2.73 (1.88–3.97) 202 (0.4) 106 (0.2) 1.93 (1.53–2.45) 1.86 (1.47–2.36)
 >360 days prior to the ID 696 (1.3) 413 (0.8) 1.70 (1.51–1.93) 1.64 (1.44–1.85) 1627 (2.9) 1088 (2.0) 1.53 (1.41–1.65) 1.50 (1.39–1.62)
Whiplash
 ≤30 days prior to (includigng) the ID 44 (0.1) 7 (0.0) 6.44 (2.90–14.30) 5.77 (2.59–12.86) 42 (0.1) 8 (0.0) 5.27 (2.47–11.22) 5.12 (2.40–10.92)
 31 to 360 days prior to the ID 160 (0.3) 112 (0.2) 1.45 (1.13–1.84) 1.41 (1.10–1.81) 185 (0.3) 120 (0.2) 1.56 (1.24–1.97) 1.54 (1.22–1.94)
 >360 days prior to the ID 2144 (4.0) 1724 (3.2) 1.26 (1.18–1.35) 1.25 (1.17–1.33) 2373 (4.2) 2054 (3.7) 1.17 (1.10–1.25) 1.16 (1.09–1.23)
Cervicalgia
 ≤30 days prior to (includigng) the ID 425 (0.8) 81 (0.2) 5.57 (4.39–7.07) 5.41 (4.26–6.88) 560 (1.0) 129 (0.2) 4.90 (4.03–5.95) 4.80 (3.94–5.83)
 31 to 360 days prior to the ID 1184 (2.2) 674 (1.3) 1.90 (1.72–2.09) 1.81 (1.64–2.00) 1816 (3.3) 1066 (1.9) 1.88 (1.74–2.03) 1.83 (1.69–1.98)
 >360 days prior to the ID 7533 (14.0) 5411 (10.0) 1.53 (1.47–1.59) 1.49 (1.43–1.55) 10,542 (18.9) 7988 (14.3) 1.48 (1.43–1.53) 1.46 (1.41–1.51)
Migraine
 ≤30 days prior to (includigng) the ID 103 (0.2) 17 (0.0) 6.16 (3.69–10.30) 5.73 (3.42–9.60) 243 (0.4) 63 (0.1) 4.09 (3.10–5.39) 3.98 (3.01–5.26)
 31 to 360 days prior to the ID 246 (0.5) 134 (0.3) 1.87 (1.51–2.31) 1.77 (1.43–2.19) 799 (1.4) 469 (0.8) 1.81 (1.62–2.04) 1.76 (1.57–1.98)
 >360 days prior to the ID 2821 (5.2) 1988 (3.7) 1.45 (1.37–1.54) 1.41 (1.33–1.49) 6698 (12.0) 5172 (9.3) 1.37 (1.32–1.42) 1.35 (1.30–1.40)
Cranial nerve disorders
 ≤30 days prior to (includigng) the ID 33 (0.1) 10 (0.0) 3.30 (1.63–6.70) 3.43 (1.68–6.99) 57 (0.1) 11 (0.0) 5.23 (2.74–9.98) 5.14 (2.69–9.83)
 31 to 360 days prior to the ID 122 (0.2) 53 (0.1) 2.36 (1.70– 3.28) 2.26 (1.62–3.14) 220 (0.4) 124 (0.2) 1.78 (1.43–2.23) 1.75 (1.40–2.19)
 >360 days prior to the ID 874 (1.6) 722 (1.3) 1.22 (1.10– 1.35) 1.21 (1.09–1.33) 1412 (2.5) 1050 (1.9) 1.36 (1.26–1.48) 1.37 (1.26–1.48)

Notes: aAdjusted for BMI category, smoking status, alcohol consumption. bFor confidentiality reasons, we do not provide the number of patients in categories containing less than five patients.

Abbreviations: CI, confidence interval; ID, index date; NA, not available; OR, odds ratio.